Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo Maffezzoni

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Minerva Endocrinologica|September 8, 2017
Acromegaly and boneFilippo Maffezzoni, Anna M Formenti
Trends in Endocrinology and Metabolism: TEM|May 28, 2016
Current and Emerging Aspects of Diabetes Mellitus in AcromegalyStefano Frara, Filippo Maffezzoni, Gherardo Mazziotti, et al.
Progress in Molecular Biology and Translational Science|March 5, 2016
The Modern Criteria for Medical Management of AcromegalyStefano Frara, Filippo Maffezzoni, Gherardo Mazziotti, et al.
Protein and Peptide Letters|September 28, 2020
INSL3: A Marker of Leydig Cell Function and Testis-Bone-Skeletal Muscle NetworkPaolo Facondo, Andrea Delbarba, Filippo Maffezzoni, et al.
Expert Opinion on Investigational Drugs|July 26, 2014
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumorsAndrea Giustina, Gherardo Mazziotti, Filippo Maffezzoni, et al.
Frontiers of Hormone Research|May 24, 2016
Skeletal Fragility in Endogenous HypercortisolismGherardo Mazziotti, Adriano Delgado, Filippo Maffezzoni, et al.
Expert Opinion on Pharmacotherapy|June 29, 2016
Current and future medical treatments for patients with acromegalyFilippo Maffezzoni, Anna Maria Formenti, Gherardo Mazziotti, et al.
Protein and Peptide Letters|April 21, 2020
Biomarkers of Acromegaly and Growth Hormone ActionFilippo Maffezzoni, Teresa Porcelli, Andrea Delbarba, et al.
Protein and Peptide Letters|April 27, 2020
Protein Markers in OsteoporosisTeresa Porcelli, Letizia Pezzaioli, Andrea Delbarba, et al.
European Journal of Endocrinology|June 17, 2020
MANAGEMENT OF ENDOCRINE DISEASE: Male osteoporosis: diagnosis and management - should the treatment and the target be the same as for female osteoporosis?Teresa Porcelli, Filippo Maffezzoni, Letizia Chiara Pezzaioli, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Minerva Endocrinologica|September 8, 2017
Acromegaly and boneFilippo Maffezzoni, Anna M Formenti
Trends in Endocrinology and Metabolism: TEM|May 28, 2016
Current and Emerging Aspects of Diabetes Mellitus in AcromegalyStefano Frara, Filippo Maffezzoni, Gherardo Mazziotti, et al.
Progress in Molecular Biology and Translational Science|March 5, 2016
The Modern Criteria for Medical Management of AcromegalyStefano Frara, Filippo Maffezzoni, Gherardo Mazziotti, et al.
Protein and Peptide Letters|September 28, 2020
INSL3: A Marker of Leydig Cell Function and Testis-Bone-Skeletal Muscle NetworkPaolo Facondo, Andrea Delbarba, Filippo Maffezzoni, et al.
Expert Opinion on Investigational Drugs|July 26, 2014
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumorsAndrea Giustina, Gherardo Mazziotti, Filippo Maffezzoni, et al.
Frontiers of Hormone Research|May 24, 2016
Skeletal Fragility in Endogenous HypercortisolismGherardo Mazziotti, Adriano Delgado, Filippo Maffezzoni, et al.
Expert Opinion on Pharmacotherapy|June 29, 2016
Current and future medical treatments for patients with acromegalyFilippo Maffezzoni, Anna Maria Formenti, Gherardo Mazziotti, et al.
Protein and Peptide Letters|April 21, 2020
Biomarkers of Acromegaly and Growth Hormone ActionFilippo Maffezzoni, Teresa Porcelli, Andrea Delbarba, et al.
Protein and Peptide Letters|April 27, 2020
Protein Markers in OsteoporosisTeresa Porcelli, Letizia Pezzaioli, Andrea Delbarba, et al.
European Journal of Endocrinology|June 17, 2020
MANAGEMENT OF ENDOCRINE DISEASE: Male osteoporosis: diagnosis and management - should the treatment and the target be the same as for female osteoporosis?Teresa Porcelli, Filippo Maffezzoni, Letizia Chiara Pezzaioli, et al.
Pageof 4